[카테고리:] Breast Imaging

A galactocele is a benign, milk-filled cyst that commonly occurs during pregnancy or lactation.

Although it may feel alarming, a galactocele is not cancer and is usually harmless.

Understanding its ultrasound features and clinical behavior helps differentiate it from other breast masses.

What Is a Galactocele?

A galactocele forms when a milk duct becomes obstructed, leading to accumulation of milk.

It most often appears:

• During late pregnancy
• During breastfeeding
• Shortly after cessation of lactation

It is one of the most common benign breast masses in lactating women.

Ultrasound Features of Galactocele

On breast ultrasound, a galactocele may appear:

• Well-circumscribed
• Round or oval
• Cystic or complex cystic
• With internal echoes due to milk components
• With posterior acoustic enhancement

The internal echogenicity can vary depending on the fat and protein content of the milk.

Fluid-fluid levels may sometimes be visible.

Recognition of these features is important to avoid unnecessary biopsy.

How Is Galactocele Different from Other Breast Masses?

Galactocele should be differentiated from:

• Fibroadenoma
• Lactating adenoma
• Abscess
• Pregnancy-associated breast cancer

Unlike solid tumors, galactoceles are typically cystic and show posterior enhancement.

Clinical history of lactation is a key diagnostic clue.

When Is Aspiration Needed?

Aspiration may be considered if:

• The mass is painful
• There is diagnostic uncertainty
• The cyst is large or causing discomfort

Fine-needle aspiration often yields milky fluid and confirms the diagnosis.

Is Galactocele Dangerous?

Galactocele is a benign condition.

It does not increase breast cancer risk.

Most cases resolve spontaneously after lactation ends.

However, persistent or atypical findings should be evaluated carefully.

Counseling Perspective

Patients often fear that any breast mass during pregnancy or breastfeeding means cancer.

It is helpful to explain:

• Galactocele is common during lactation
• Ultrasound findings are usually characteristic
• Most cases require no surgery

Clear explanation reduces unnecessary anxiety.

❓ Is breast ultrasound better than mammography for dense breasts?




Breast ultrasound is not better than mammography, but it can detect certain cancers that may be hidden in dense breast tissue. It is typically used as a supplemental screening tool rather than a replacement.








❓ Can ultrasound detect cancer in dense breasts?




Yes, breast ultrasound can detect small solid masses that may not be visible on mammography due to dense tissue. However, it may also increase false-positive findings.








❓ Do all women with dense breasts need ultrasound?




Not necessarily. Supplemental ultrasound may be considered for women with dense breasts and additional risk factors. Screening decisions should be individualized.








❓ Does having dense breasts increase cancer risk?




Dense breast tissue is associated with a modestly increased risk of breast cancer. However, density alone does not mean cancer is present.








❓ Is dense breast ultrasound covered by insurance?




Coverage depends on country, state laws, and insurance policies. In some regions, supplemental screening for dense breasts may be covered.

Many women are told after a mammogram:

“You have dense breasts.”

This often leads to the next question:

“Should I get a breast ultrasound?”

Understanding how dense breast ultrasound works — and when it is helpful — is essential.

What Does “Dense Breast” Mean?

Breast density refers to the proportion of:

• Fibroglandular tissue
• Fatty tissue

on mammography.

Dense breasts appear white on mammograms —

and so do many cancers.

This makes detection more challenging.

Why Is Mammography Less Sensitive in Dense Breasts?

In dense breast tissue:

• Cancer may be masked
• Sensitivity of mammography decreases
• Small lesions may be obscured

This is sometimes referred to as the “masking effect.”

How Does Breast Ultrasound Help?

Breast ultrasound does not rely on tissue density in the same way as mammography.

It can:

• Detect small solid masses
• Differentiate cysts from solid lesions
• Identify lesions hidden in dense tissue

Studies show that supplemental ultrasound may detect additional cancers in women with dense breasts.

What Are the Limitations of Dense Breast Ultrasound?

Ultrasound:

• May increase false positives
• Can lead to additional biopsies
• Is operator-dependent

It is not a replacement for mammography —

but rather a complementary tool.

Who Should Consider Breast Ultrasound?

Dense breast ultrasound may be considered in:

• Women with heterogeneously or extremely dense breasts
• Women with additional risk factors
• Those seeking supplemental screening

Clinical discussion with a healthcare provider is important.

Counseling Perspective

Patients often feel alarmed when told they have dense breasts.

It helps to explain:

• Dense breast tissue is common
• It does not mean cancer is present
• Ultrasound may provide additional reassurance

Balanced information reduces anxiety while supporting informed decisions.

Final Thoughts

Dense breast ultrasound can improve cancer detection in selected patients.

However, it should be used as a supplement — not a substitute — for mammography.

Imaging decisions should consider breast density, risk factors, and patient preference.

Breast ultrasound is widely used to evaluate lumps, dense breast tissue, and abnormal findings seen on mammography.

But many patients ask:

“How accurate is breast ultrasound?”

“Can ultrasound detect breast cancer reliably?”

The answer depends on context.

What Breast Ultrasound Is Good At

Breast ultrasound is particularly accurate for:

• Distinguishing cystic vs solid masses
• Evaluating palpable lumps
• Assessing dense breast tissue
• Guiding biopsies

In experienced hands, ultrasound has high sensitivity for detecting suspicious solid masses.

Sensitivity and Detection Rates

Studies show:

• Sensitivity of breast ultrasound for cancer detection can range from 60–95%, depending on patient population
• When combined with mammography, detection rates increase
• In dense breasts, ultrasound may detect cancers not visible on mammography

However, ultrasound is operator-dependent.

Experience matters.

What Ultrasound May Miss

Ultrasound is less effective for:

• Detecting microcalcifications
• Screening the entire breast in asymptomatic patients (compared to mammography)
• Identifying certain early-stage cancers

It is not typically used as a standalone screening tool for average-risk women.

Is Breast Ultrasound Reliable?

Breast ultrasound is reliable when:

• Evaluating a specific area of concern
• Assessing a palpable mass
• Used in combination with other imaging

Reliability increases with:

• Proper technique
• Experience
• Correlation with clinical findings

No imaging modality is 100% accurate.

Why Technique Matters

Image quality depends on:

• Proper probe selection
• Adequate compression
• Systematic scanning pattern
• Recognition of subtle architectural distortion

Ultrasound is dynamic — interpretation happens in real time.

A static image does not tell the full story.

Counseling Perspective

When patients ask about accuracy, reassurance should be balanced.

It is helpful to explain:

• Ultrasound is very good at evaluating lumps
• It complements mammography
• If findings are suspicious, biopsy confirms diagnosis

Accuracy is about combining imaging tools wisely — not relying on one test alone.

Final Thoughts

Breast ultrasound is a powerful diagnostic tool, especially for dense breasts and palpable masses.

Its accuracy depends on context, technique, and experience.

Used appropriately, it plays a crucial role in breast cancer detection and evaluation.

A cancer diagnosis during pregnancy raises urgent and complex questions.

One of the most difficult is:

“Is radiation therapy safe during pregnancy?”

The answer depends on gestational age, radiation dose, and treatment location.

How Radiation Affects the Fetus

Radiation exposure risk depends on:

• Dose (measured in Gy or mGy)
• Gestational age
• Distance between treatment field and uterus

The fetus is most vulnerable during early organ development.

First Trimester: Highest Sensitivity

During weeks 2–12:

• Organogenesis occurs
• Risk of miscarriage increases
• Risk of congenital malformations rises

Radiation therapy is generally avoided in the first trimester whenever possible.

Second and Third Trimester: Risk Depends on Dose

After organ formation:

• Risk of structural malformations decreases
• Growth restriction and neurodevelopmental effects remain concerns at higher doses

If the radiation field is far from the uterus (e.g., brain tumors), fetal exposure may be minimal.

However, direct pelvic radiation is contraindicated during pregnancy.

Can Radiation Ever Be Considered?

Radiation therapy during pregnancy may be considered only if:

• The maternal condition is life-threatening
• Alternative treatments are not available
• Fetal exposure can be minimized with shielding and planning

Each case requires a multidisciplinary team including:

• Oncologists
• Obstetricians
• Medical physicists

Breast Cancer and Radiation

For pregnancy-associated breast cancer:

• Surgery is often performed during pregnancy
• Chemotherapy may be given in later trimesters
• Radiation therapy is usually postponed until after delivery

This approach minimizes fetal radiation exposure.

Fetal Radiation Exposure Risk

Estimated fetal risks depend on cumulative dose:

• <50 mGy → minimal measurable risk
• 100 mGy → increased concern for developmental effects
• Very high doses → risk of fetal loss or severe impairment

Modern radiation planning reduces scatter exposure significantly.

Counseling Perspective

Patients may assume all radiation equals severe harm.

It is important to clarify:

• Diagnostic ultrasound is safe
• Radiation risk depends on dose and location
• Many cancer treatments can be modified during pregnancy

Balancing maternal survival with fetal safety requires individualized planning.

Final Thoughts

Radiation therapy during pregnancy is generally avoided — especially in early gestation.

In rare, life-threatening situations, carefully planned treatment may be considered.

Multidisciplinary care ensures that both maternal and fetal risks are carefully evaluated.

A diagnosis of cancer during pregnancy raises one urgent question:

“Is chemotherapy safe during pregnancy?”

Balancing maternal treatment and fetal safety requires careful timing, multidisciplinary care, and evidence-based decision-making.

Can Chemotherapy Be Given During Pregnancy?

Yes — in selected cases.

Chemotherapy safety depends largely on gestational age.

First Trimester: High Risk Period

During the first trimester (weeks 1–12):

• Organ development occurs
• Risk of miscarriage increases
• Risk of congenital malformations is highest

Chemotherapy is generally avoided during the first trimester whenever possible.

Second and Third Trimester: Safer Window

Research shows that certain chemotherapy regimens can be administered more safely during:

• Second trimester
• Third trimester

Studies suggest:

• No significant increase in congenital malformations
• Slight risk of preterm birth
• Possible low birth weight

Long-term neurodevelopmental outcomes in many cases are reassuring.

Common Cancers Treated During Pregnancy

• Breast cancer
• Lymphoma
• Leukemia (selected cases)

Treatment plans are individualized based on cancer type and stage.

What About Delivery Timing?

Chemotherapy is usually stopped:

• 3–4 weeks before planned delivery

This reduces risks of maternal and neonatal complications related to bone marrow suppression.

Is the Baby Affected Long-Term?

Available follow-up studies suggest:

• Normal cognitive development in many children
• No consistent evidence of major developmental delay

However, long-term data are still evolving.

Close pediatric follow-up is recommended.

Counseling Perspective

Patients often fear that chemotherapy automatically harms the baby.

It is important to explain:

• Timing matters
• Multidisciplinary teams coordinate care
• Treatment decisions prioritize both maternal survival and fetal safety

Delaying necessary treatment can worsen maternal outcomes.

Evidence-based care allows many women to safely continue pregnancy while receiving cancer therapy.

Final Thoughts

Chemotherapy during pregnancy is not universally unsafe — but timing and regimen selection are critical.

Second and third trimester chemotherapy may be administered with careful monitoring.

Maternal health and fetal safety are not mutually exclusive goals when managed appropriately.

Pregnancy brings many changes to the breasts — enlargement, tenderness, and nodularity are common.

However, in rare cases, a persistent breast mass during pregnancy may represent pregnancy-associated breast cancer (PABC).

Early recognition is critical because physiological breast changes can delay diagnosis.

What Is Pregnancy-Associated Breast Cancer?

Pregnancy-associated breast cancer refers to breast cancer diagnosed:

• During pregnancy
• Within one year postpartum

Although uncommon, it is the most common cancer diagnosed during pregnancy.

Why Is Diagnosis Challenging?

Hormonal changes during pregnancy cause:

• Increased breast density
• Enlargement of glandular tissue
• Increased vascularity

These changes can mask early cancer signs on physical exam.

Patients and clinicians may attribute symptoms to normal pregnancy changes — leading to delayed evaluation.

Early Signs of Pregnancy-Associated Breast Cancer

The following symptoms should not be ignored:

🔎 Persistent Breast Mass

A lump that does not resolve after several weeks requires imaging evaluation.

🔎 Rapid Progressive Growth

Rapid enlargement unrelated to milk production may raise concern.

🔎 Irregular or Hard Texture

Non-mobile, firm masses warrant further investigation.

🔎 Skin Changes

• Dimpling
• Thickening
• Redness not consistent with mastitis

🔎 Nipple Changes

• Retraction
• Bloody discharge

🔎 Enlarged Axillary Lymph Nodes

Palpable lymph nodes may require ultrasound assessment.

Is Imaging Safe During Pregnancy?

Yes.

Breast ultrasound is the first-line imaging modality because it:

• Uses no radiation
• Differentiates cystic vs solid lesions
• Guides biopsy safely

Mammography with abdominal shielding may be considered if necessary.

Is Biopsy Safe During Pregnancy?

Core needle biopsy is generally safe during pregnancy and should not be delayed if imaging findings are suspicious.

Early diagnosis improves treatment options and outcomes.

Counseling Perspective

It is important to reassure patients:

• Most breast lumps during pregnancy are benign
• However, persistent or suspicious findings require evaluation
• Early imaging does not harm the baby

Balancing reassurance with vigilance is essential.

Final Thoughts

Pregnancy-associated breast cancer is rare but real.

A persistent breast mass during pregnancy should never be dismissed without proper imaging evaluation.

Early recognition and timely diagnosis protect both mother and baby.